Tech · Detection · TechCare Alert

Detect, triage, at acquisition.

Triage and diagnostic support across the radiography workflow. Computer vision for trauma and chest imaging: fractures, dislocations, joint effusions, pneumothorax, opacities, nodules and pleural effusions (Europe coverage). Every exam is analyzed at acquisition. Exams with a finding move up the worklist.

In short. TechCare Alert is Milvue's AI software that analyses every radiograph at acquisition and flags fractures, dislocations, joint effusions, pneumothorax, opacities, nodules and pleural effusions. Exams with a finding move up the worklist. CE marked, Class IIa medical device in Europe, for all ages, from birth, outside critical care units. In the United States, TechCare Trauma is FDA 510(k) cleared (K242171); in Canada, SmartTrauma is licensed by Health Canada.

Milvue Suite, CE 2797, Class IIaAdult & pediatric
Real Milvue Suite output: joint effusion flagged on a lateral elbow radiograph
DETECTION
Real Milvue Suite output: elbow joint effusion.
Ranking
No. 1
adult & pediatric fractures
Sensitivity
+ 22 %
reader sensitivity, adult fractures
Lung nodule
0.86 AUC
vs 0.81 for 17 readers (van Leeuwen, Radiology 2024)
ED wait time
− 1  h
waiting in the ED, about · Aalborg University Hospital (North Denmark Region, 2024)
What detection does

Seven pathology families, one pass.

Detection covers musculoskeletal trauma and chest findings. The AI flags, localizes and returns the results; the radiologist stays in charge.

  • Fractures, dislocations, joint effusions
  • Pneumothorax, opacities, nodules, pleural effusions (Europe)
  • +22% reader sensitivity on adult fractures, 24% less reading time
  • Worklist prioritization
DICOM CR / DXSR pre-reportNo age limit (EU)ISO 13485 (BSI, certificate MD 709839)
Real Milvue Suite output: pulmonary nodule flagged on a chest radiograph
Real Milvue Suite output: pulmonary nodule flagged on a chest radiograph.
In practice

Three steps, no workstation change.

Nothing to change at the reading station: the solution slots into your existing flow.

01

Acquisition

The exam flows from the modality to the Milvue Suite, with no protocol change.

02

AI analysis

Detection and localization of findings, at acquisition.

03

Worklist

Exams with a finding move up the worklist. Results insert into the report.

This AI accurately identifies fractures and several chest abnormalities, including the most difficult ones. Displayed directly on our reading stations, TechCare Alert acts as an effective second reader.

Dr Bassem Marghany · International Radiology Center, Sharjah
90%of misread ED cases caught (Parpaleix, Eur J Radiol Open, 2023)
0.962fracture AUC, adults and children
7pathology families
Spec sheet

At a glance.

CE-marked medical device, Class IIa, developed by Milvue. Native integration, protected data.

ModalitiesStandard radiography (CR / DX)
RegionsSkeleton, chest (chest findings: Europe only)
PopulationAdult and pediatric, no age limit, outside critical care (EU)
OutputOn-image results (DICOM SC, overlay, GSPS) and summary image · pre-filled narrative report, fitted to the standard report template
IntegrationNative RIS / PACS, DICOM in / out · IHE profiles (Connectathons)
DeviceMilvue Suite, CE 2797, Class IIa · TechCare Trauma, FDA 510(k) cleared (US) · SmartTrauma, licensed by Health Canada

Regulatory detail:

  • In the United States, fracture detection is TechCare Trauma; in Canada, SmartTrauma.
  • The Milvue Suite software, developed by the Milvue company, is a Class IIa medical device within the meaning of EU Regulation MDR 2017/745 - Notified Body: BSI, CE 2797. TechCare Alert and TechCare Metrics are the commercial designations of its SmartUrgences® and SmartXpert® modules. Read the instructions for use carefully.
  • TechCare Trauma, developed by Milvue, is FDA 510(k) cleared (K242171) as a Class II device (21 CFR 892.2090). It is intended to aid clinicians and does not replace their judgment. Rx only. See the IFU for indications and warnings.
  • SmartTrauma (MILVUE SUITE - SMARTTRAUMA, licence 108963) is a Class II medical device licensed by Health Canada. Manufacturer: Milvue. Read the instructions for use carefully.

Page updated on November 2, 2026.

Frequently asked questions
Which findings does TechCare Alert detect?

On radiographs: fractures, dislocations and joint effusions, in adults and children alike; in Europe, also pneumothorax, opacities, nodules and pleural effusions. Every exam is analysed at acquisition and detected findings are marked on the image.

How accurate is TechCare Alert for fracture detection?

In an independent emergency department study comparing three commercial algorithms on 1,210 patients (Bousson et al., Academic Radiology, 2023), Milvue achieved the highest diagnostic accuracy in fracture detection. The AI raised reader sensitivity for adult fractures by 22%.

Is TechCare Alert a medical device?

Yes. In Europe, the Milvue Suite is a CE marked, Class IIa medical device (EU MDR 2017/745, notified body BSI, CE 2797), for patients of all ages, from birth, outside critical care units. In the United States, TechCare Trauma is FDA 510(k) cleared (K242171); in Canada, SmartTrauma is licensed by Health Canada (Class II). In the United Kingdom, NICE lists TechCare Alert among the four AI technologies that can be used in the NHS to help detect fractures, for people of any age, during the evidence generation period (HTG739, January 2025).

NEW TECHNEW CARE

See the emergency before it hides.